Thursday 18 Sep 2014

Vermillion Inc. (NASDAQ:VRML) down by 6.45%, DARA Biosciences Inc (NASDAQ:DARA)

New York, NY – (NISMAGAZINE) – 06/12/2013- Vermillion Inc. (NASDAQ:VRML) went down by 6.45% to trade at $2.90, with a volume of 264K shares. The short float created in the stock is close to 2.07% while the short ratio is standing at 1.43. The stock is currently 28.72% off its 52-week high of $4.07 and 181.65% above its 52-week low of $1.03. The insiders own 1.15% of the outstanding shares while the institutions hold 7.25% of the outstanding shares. The stock has given a return of 2.65% over the last 5 trading sessions and a return of 124.64% over the past quarter. The volatility experienced by the stock during the last 5 trading session is close to 10.73%, while the volatility during the last month was 11.85%. The earnings per share is -$0.48 for the trailing twelve months.

Vermillion received a new statement by the Society of Gynecologic Oncology on clinical validation and medical use. SGO stated that the test will be help in identifying women to be referred to a gynecologic oncologist. The OVA1 test together with physician clinical assessment will help in improving the rates of detection of malignancies in women with pelvic masses planning surgery.

Is VRML a solid investment at these levels? Find out here.

DARA Biosciences Inc (NASDAQ:DARA) went down by 3.11% to trade at $0.705, with a volume of 279K shares. The short float created in the stock is close to 7.24% while the short ratio is standing at 4.52. The stock is currently 48.66% off its 52-week high of $1.38 and 14.27% above its 52-week low of $0.62. The insiders own 1.62% of the outstanding shares while the institutions hold 5.17% of the outstanding shares. The stock has given a return of 8.96% over the last 5 trading sessions and a return of -29.81% over the past quarter. The volatility experienced by the stock during the last 5 trading session is close to 5.70%, while the volatility during the last month was 5.39%. The analysts are targeting a price of $2.00 for the stock. The growth in earnings per share expected this year is close to 90.60%, or the expected EPS is -$0.03 as compared to earnings per share of -$0.51 for the trailing twelve months.

How Should Investors Trade DARA Now? Find out here.

About HiddenGemStocks.com

Subscribe for FREE to receive our “50 Stock Trading Rules No Hedge Fund Wants You To Know!” E-Book: http://hiddengemstocks.com/trade.html

HiddenGemStocks.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:

HiddenGemStocks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HiddenGemStocks.com website, for complete risks and disclosures.

Contact:

Gale Wills

info@hiddengemstocks.com

Leave a Comment